Shanghai Sundise Chinese Medicine Technology Development

Shanghai Sundise Traditional Chinese Medicine Technology Development is a pharmaceutical company specializing in the modernization and industrialization of Traditional Chinese Medicine (TCM). As a subsidiary of Shanghai Pharmaceuticals, the company focuses on the research and production of high-quality botanical extracts, most notably its proprietary Ginkgo biloba leaf extract products marketed under the brand Xingling. These products are widely used in China for the treatment of cardiovascular and cerebrovascular conditions, including coronary heart disease and cerebral infarction. Sundise leverages modern extraction technologies and rigorous quality control to bridge the gap between traditional herbal remedies and evidence-based medicine. The company is headquartered in the Zhangjiang Hi-Tech Park in Shanghai, reflecting its commitment to pharmaceutical innovation.